Dose-dense cisplatin-based chemotherapy and surgery for children with high-risk hepatoblastoma (SIOPEL-4): a prospective, single-arm, feasibility study
ContributorsZsiros, József; Brugieres, Laurence; Brock, Penelope; Roebuck, Derek; Maibach, Rudolf; Zimmermann, Arthur; Childs, Margaret; Pariente, Daniele; Laithier, Veronique; Otte, Jean-Bernard; Branchereau, Sophie; Aronson, Daniel; Rangaswami, Arun; Ronghe, Milind; Casanova, Michela; Sullivan, Michael; Morland, Bruce; Czauderna, Piotr; Perilongo, Giorgio; International childhood liver tumours strategy group
CollaboratorsOzsahin, Ayse Hulya
Published inLancet oncology, vol. 14, no. 9, p. 834-842
Publication date2013
Abstract
Keywords
- Adolescent
- Antineoplastic Combined Chemotherapy Protocols/therapeutic use
- Child
- Child, Preschool
- Cisplatin/administration & dosage
- Combined Modality Therapy
- Dose-Response Relationship, Drug
- Doxorubicin/administration & dosage
- Feasibility Studies
- Female
- Follow-Up Studies
- Hepatectomy
- Hepatoblastoma/mortality/pathology/therapy
- Humans
- Liver Neoplasms/mortality/pathology/therapy
- Lung Neoplasms/mortality/secondary/therapy
- Male
- Prognosis
- Prospective Studies
- Survival Rate
Research group
Citation (ISO format)
ZSIROS, József et al. Dose-dense cisplatin-based chemotherapy and surgery for children with high-risk hepatoblastoma (SIOPEL-4): a prospective, single-arm, feasibility study. In: Lancet oncology, 2013, vol. 14, n° 9, p. 834–842. doi: 10.1016/S1470-2045(13)70272-9
Main files (1)
Article (Published version)
Identifiers
- PID : unige:44657
- DOI : 10.1016/S1470-2045(13)70272-9
- PMID : 23831416
ISSN of the journal1470-2045
